Helsinn Healthcare SA
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 1976-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.helsinn.com
XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2004-08-23
- Last Posted Date
- 2009-01-14
- Lead Sponsor
- Helsinn Healthcare SA
- Target Recruit Count
- 248
- Registration Number
- NCT00090025
- Locations
- 🇺🇸
Case Western Reserve University, Cleveland, Ohio, United States
🇮🇹Policlinico Universitario di Udine, Udine, Italy
🇨🇦Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada
© Copyright 2024. All Rights Reserved by MedPath